You are here: Industry Insights > COVID-19

News List

GSK, Vir Biotechnology to evaluate neutralising Covid-19 antibody in AGILE study pharmaceutical-business-review
January 14, 2021
GlaxoSmithKline, along with Vir Biotechnology, has agreed with the UK-based AGILE initiative to assess VIR-7832 in patients with mild to moderate Covid-19 in a phase 1b/2a clinical study.
Synairgen begins large-scale trial of inhaled COVID-19 treatment pharmatimes
January 14, 2021
Southampton, UK-headquartered company Synairgen has treated the first patient in the UK as part of a global Phase III trial evaluating its inhaled COVID-19 treatment SNG001 in hospitalised patients.
New findings help explain how COVID-19 overpowers the immune system worldpharmanews
January 13, 2021
Seeking to understand why COVID-19 is able to suppress the body's immune response, new research from the USC Leonard Davis School of Gerontology suggests that mitochondria are one of the first lines of defense against COVID-19 and identifies key ...
Valeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin and Vitamin C for COVID-19 prnewswire
January 13, 2021
Valeo Pharma Inc. , a Canadian pharmaceutical company, provided comments on a recently issued newsletter by MDBriefCase entitled "Exploring Novel Therapeutic Approaches for Covid-19: Hesperidin vs Vitamin C".
FDA GRANTS ADVAITE EMERGENCY USE AUTHORIZATION FOR RapCov? Rapid COVID-19 Test prnewswire
January 13, 2021
The U.S. Food and Drug Administration has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE Inc., an innovative biotech company developing novel point-of-care assays to help with ...
Ortho's VITROS? SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization prnewswire
January 13, 2021
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS? SARS-CoV-2 Antigen Test, designed to detect active infection, has become the first high-volume COVID-19 antigen test to receive ...
FDA Grants Advaite Emergency Use Authorization FOR RapCov Rapid COVID-19 Test americanpharmaceuticalreview
January 13, 2021
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE.
CohBar, NIAID to assess CB5064 Analogs for Covid-19 treatment pharmaceutical-technology
January 13, 2021
CohBar and the US National Institute of Allergy and Infectious Diseases (NIAID) have signed a non-clinical evaluation agreement (NCEA) to analyse CB5064 Analogs for treating Covid-19 related Acute Respiratory Distress Syndrome (ARDS).
iosBio Inks Exclusive Vax Platform Pact for COVID-19 contractpharma
January 13, 2021
OraPro oral delivery vaccine platform technology enables oral administration of thermally-stable, viral vector vaccines.
FDA approves Phase III trial of synthetic biological COVID-19 treatment europeanpharmaceuticalreview
January 12, 2021
The international Phase III trial will evaluate whether a 14 day course of carrimycin can improve outcomes for COVID-19 patients with severe symptoms.